查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2041743

胰島素輸注裝置市場預測至2034年：按產品、通路、最終用戶和地區分類的全球分析

Insulin Delivery Devices Market Forecasts to 2034 - Global Analysis By Product (Insulin Pumps, Insulin Pens, Insulin Pen Needles, Insulin Syringes, Insulin Inhalers, Insulin Jet Injectors and Other Types), Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 預測，全球胰島素輸送設備市場預計將在 2026 年達到 195 億美元，並在預測期內以 9.4% 的複合年成長率成長，到 2034 年達到 400 億美元。

胰島素輸注裝置是專為糖尿病患者設計的胰島素輸注儀器或系統。它們透過將胰島素輸送到體內來調節血糖值。這些裝置有多種形式，包括胰島素注射器、胰島素筆、胰島素幫浦和胰島素噴射注射器。它們提供不同的胰島素輸注方式，使患者能夠根據自身的生活方式、偏好和胰島素需求更有效地管理病情。

根據國際糖尿病聯盟（IDF）的數據，2021年全球約有5.37億成年人患有糖尿病，預計2030年將增加到6.43億。

糖尿病盛行率上升

糖尿病盛行率的不斷上升推動了胰島素輸注裝置的進步。創新技術滿足了多樣化的需求，兼具便利性和精準性。從傳統注射器到先進的胰島素幫浦和胰島素筆，科技革新了糖尿病管理。智慧型設備整合了監測和輸注功能，提高了患者的自主性。這些設備不僅改善了治療依從性，還提升了糖尿病患者的生活品質，代表著糖尿病護理領域的一項重大進步。

技術問題

胰島素輸注裝置容易出現技術故障，影響胰島素的輸注。這些故障可能導致胰島素輸注不當，進而引發高血糖或低血糖。機械故障，例如針頭堵塞或幫浦堵塞，需要立即更換，這可能會造成不便併中斷胰島素治療。這些技術缺陷凸顯了使用者關注和定期檢查裝置的重要性，以確保胰島素輸注的順暢和安全。這些因素正在阻礙市場成長。

引入支持措施

胰島素輸注設備的支持性舉措徹底改變了糖尿病治療。智慧胰島素幫浦、整合式連續血糖監測和使用者友善介面等進步簡化了管理流程。此外，自動化胰島素輸注演算法等技術主導的功能實現了精準的即時調整。採用這些創新不僅賦予病人更多自主權，也促進了醫護人員與糖尿病病人之間的協作。這些因素正是推動市場成長的動力。

高成本

胰島素輸注裝置的高成本是一個顯著的缺點，主要影響糖尿病患者的可及性和經濟承受能力。這種經濟負擔往往限制了患者獲得必要設備，導致治療不足或治療中斷。當難以負擔時，持續血糖值監測和有效的胰島素輸注可能無法實現，這可能會損害患者的健康。這些因素限制了市場成長。

新冠疫情的感染疾病：

生產中斷、運輸問題以及醫療用品需求增加導致某些醫療器材間歇性短缺和供應延遲。疫情凸顯了醫療器材消毒和安全措施的重要性。製造商和使用者都更加謹慎地確保胰島素輸注裝置得到正確清潔和維護，以最大程度地降低感染風險。

在預測期內，胰島素筆細分市場預計將成為最大的細分市場。

在預測期內，胰島素筆市場預計將佔據最大佔有率。與其他產品相比，胰島素筆的優勢、高滲透率、人性化設計以及日益成長的消費者支持，都促成了其最大的銷售佔有率。推動這一高佔有率的主要因素之一是製造商日益重視創新和技術進步。因此，在不久的將來，產品創新可望進一步推動胰島素筆的需求。

預計在預測期內，居家照護領域將呈現最高的複合年成長率。

由於人們對糖尿病照護的認知不斷提高，預計居家照護領域在預測期內將呈現最高的複合年成長率。在家使用胰島素輸注設備可以減少等待時間、降低醫院和診所費用以及差旅費。先進的設備，例如胰島素筆、注射器和胰島素泵，體積小巧、方便攜帶且始終實用。易用性和可近性的提高促使胰島素使用者選擇自我護理糖尿病管理方案。

市佔率最大的地區：

預計北美將在預測期內佔據最大的市場佔有率。該地區市場規模龐大，主要受多種因素驅動，例如糖尿病盛行率上升、胰島素輸送系統技術進步以及人口老化。此外，醫療機構、製造商和研究機構在創新胰島素輸送裝置研發方面的合作，也進一步推動了該地區的市場成長。

複合年成長率最高的地區：

預計亞太地區在預測期內將維持最高的複合年成長率。該地區市場正經歷顯著成長，這主要得益於多種因素，包括糖尿病盛行率上升、人們對先進胰島素輸注技術的認知度提高以及多個國家醫療基礎設施的改善。此外，政府為促進糖尿病管理而採取的措施以及胰島素輸注系統的技術進步也推動了市場擴張。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球胰島素輸注裝置市場：依產品分類

  • 胰島素幫浦
    • 無內胎
    • 有線型
  • 胰島素筆
    • 可重複使用的
    • 拋棄式的
  • 胰島素筆針頭
    • 安全
    • 標準
  • 胰島素注射器
  • 胰島素吸入器
  • 胰島素噴射注射器
  • 其他類型

第6章 全球胰島素輸注設備市場：依通路分類

  • 線上銷售
  • 醫院藥房
  • 零售藥房

第7章 全球胰島素輸注設備市場：以最終用戶分類

  • 居家照護
  • 診所
  • 其他最終用戶

第8章 全球胰島素輸注裝置市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第9章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第10章：公司簡介

  • Abbott Laboratories
  • Novo Nordisk A/S
  • Wockhardt Ltd.
  • Medtronic
  • F. Hoffmann-La Roche, Ltd.
  • Becton, Dickinson and Company
  • Sanofi
  • Eli Lilly and Company
  • Biocon Ltd.
  • Roche
  • Insulet Corporation
  • B Braun Melsungen AG
  • Tandem Diabetes Care
  • Embecta Corporation
  • Ypsomed AG
Product Code: SMRC24806

According to Stratistics MRC, the Global Insulin Delivery Devices Market is accounted for $19.5 billion in 2026 and is expected to reach $40.0 billion by 2034 growing at a CAGR of 9.4% during the forecast period. Insulin delivery devices are tools or systems designed to administer insulin to individuals with diabetes. They're used to regulate blood sugar levels by delivering insulin into the body. These devices come in various forms, such as insulin syringes, insulin pens, insulin pumps, and insulin jet injectors. They provide different methods for insulin administration, allowing individuals to manage their condition more effectively based on their lifestyle, preferences, and insulin needs.

According to International Diabetes Federation (IDF), the adult diabetes population in 2021 was approximately 537 million, and this number is expected to increase by 643 million in 2030.

Market Dynamics:

Driver:

Rising prevalence of diabetes

The rising prevalence of diabetes has fuelled advancements in insulin delivery devices. Innovations cater to diverse needs, offering convenience and precision. From traditional syringes to advanced insulin pumps and pens, technology has revolutionized management. Smart devices integrate monitoring with delivery, enhancing patient autonomy. These devices not only improve adherence but also enhance quality of life for individuals managing diabetes, marking a significant stride in diabetes care.

Restraint:

Technical issues

Insulin delivery devices can encounter technical glitches impacting insulin administration. Malfunctions pose risks of incorrect insulin delivery, leading to hyper or hypoglycemia. Mechanical failures, like needle jams or pump blockages, necessitate immediate replacement, potentially causing inconvenience or interruptions in insulin therapy. These technical drawbacks highlight the importance of user vigilance and regular device checks to ensure seamless and safe insulin delivery. These are the factors restraining the growth of the market.

Opportunity:

Adoption of facilitative initiatives

Facilitative initiatives in insulin delivery devices have revolutionized diabetic care. Advances like smart pumps, continuous glucose monitoring integration, and user-friendly interfaces streamline management. Additionally, tech-driven features, such as automated insulin delivery algorithms, offer precise, real-time adjustments. Embracing these innovations not only empowers patients but also fosters a collaborative approach between healthcare providers and individuals managing diabetes. These are the factors propelling the growth of the market.

Threat:

High cost

The high cost of insulin delivery devices poses significant disadvantages, primarily affecting accessibility and affordability for individuals managing diabetes. This financial burden often restricts access to essential equipment, leading to inadequate or inconsistent treatment. Limited affordability can result in compromised health outcomes due to the inability to consistently monitor blood sugar levels or administer insulin effectively. These are the aspects limiting the growth of the market.

Covid-19 Impact:

Manufacturing slowdowns, transportation issues, and increased demand for medical supplies led to intermittent shortages and delays in availability for certain devices. The pandemic emphasized the importance of device sanitization and safety measures. Manufacturers and users paid more attention to ensuring that insulin delivery devices were properly cleaned and maintained to minimize the risk of infection.

The insulin pens segment is expected to be the largest during the forecast period

The insulin pens segment is expected to be the largest during the forecast period. ts advantages over other products. Its high adoption rate, user-friendly design, and growing consumer appeal were some of the factors that led to this segment's highest revenue share. A significant contributing aspect to the high share is the increasing emphasis that manufacturers are placing on innovation and advances. Therefore, it is anticipated that in the near future, product innovations will drive the demand for insulin pens.

The home care segment is expected to have the highest CAGR during the forecast period

The home care segment is expected to have the highest CAGR during the forecast period due to increasing awareness of diabetes care. Insulin devices used at home reduce waiting times, hospital or clinic fees, and visitation expenses. The cutting-edge gadgets, which come in the form of pens, injectors, and pumps, are compact, extremely portable, and always useful. Because of their increased usability and increased accessibility, insulin users are choosing self-care diabetes control solutions.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. The market in the region has been significant, driven by various factors such as the increasing prevalence of diabetes, technological advancements in insulin delivery systems, and the growing aging population. Additionally, collaborations between healthcare providers, manufacturers, and research institutions for developing innovative insulin delivery devices have further propelled market growth in the region.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. The market in the region has been witnessing significant growth due to various factors such as the rising prevalence of diabetes, increasing awareness about advanced insulin delivery technologies, and improving healthcare infrastructure in several countries. Moreover, government initiatives promoting diabetes management and technological advancements in insulin delivery systems contribute to the market's expansion.

Key players in the market

Some of the key players in Insulin Delivery Devices market include Abbott Laboratories, Novo Nordisk A/S, Wockhardt Ltd., Medtronic, F. Hoffmann-La Roche, Ltd., Becton, Dickinson and Company, Sanofi, Eli Lilly and Company, Biocon Ltd., Roche, Insulet Corporation, B Braun Melsungen AG, Tandem Diabetes Care, Embecta Corporation and Ypsomed AG.

Key Developments:

In June 2023, Novo Nordisk entered negotiations of acquiring BIOCORP, which specialized in the design and development of medical devices. This was done for the development of FlexTouch Pen with Mallya, an add-on Bluetooth device.

In Feb 2023, Lilly and IABL, the largest healthcare provider collaborated to provide high-quality and affordable insulin in Bangladesh.

Types Covered:

  • Insulin Pumps
  • Insulin Pens
  • Insulin Pen Needles
  • Insulin Syringes
  • Insulin Inhalers
  • Insulin Jet Injectors
  • Other Types

Distribution Channels Covered:

  • Online Sales
  • Hospital Pharmacies
  • Retail Pharmacies

End Users Covered:

  • Homecare
  • Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Insulin Delivery Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Insulin Pumps
    • 5.2.1 Tubeless
    • 5.2.2 Tethered
  • 5.3 Insulin Pens
    • 5.3.1 Reusable
    • 5.3.2 Disposable
  • 5.4 Insulin Pen Needles
    • 5.4.1 Safety
    • 5.4.2 Standard
  • 5.5 Insulin Syringes
  • 5.6 Insulin Inhalers
  • 5.7 Insulin Jet Injectors
  • 5.8 Other Types

6 Global Insulin Delivery Devices Market, By Distribution Channel

  • 6.1 Introduction
  • 6.2 Online Sales
  • 6.3 Hospital Pharmacies
  • 6.4 Retail Pharmacies

7 Global Insulin Delivery Devices Market, By End User

  • 7.1 Introduction
  • 7.2 Homecare
  • 7.3 Clinics
  • 7.4 Other End Users

8 Global Insulin Delivery Devices Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott Laboratories
  • 10.2 Novo Nordisk A/S
  • 10.3 Wockhardt Ltd.
  • 10.4 Medtronic
  • 10.5 F. Hoffmann-La Roche, Ltd.
  • 10.6 Becton, Dickinson and Company
  • 10.7 Sanofi
  • 10.8 Eli Lilly and Company
  • 10.9 Biocon Ltd.
  • 10.10 Roche
  • 10.11 Insulet Corporation
  • 10.12 B Braun Melsungen AG
  • 10.13 Tandem Diabetes Care
  • 10.14 Embecta Corporation
  • 10.15 Ypsomed AG

List of Tables

  • Table 1 Global Insulin Delivery Devices Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Insulin Delivery Devices Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Insulin Delivery Devices Market Outlook, By Insulin Pumps (2023-2034) ($MN)
  • Table 4 Global Insulin Delivery Devices Market Outlook, By Tubeless (2023-2034) ($MN)
  • Table 5 Global Insulin Delivery Devices Market Outlook, By Tethered (2023-2034) ($MN)
  • Table 6 Global Insulin Delivery Devices Market Outlook, By Insulin Pens (2023-2034) ($MN)
  • Table 7 Global Insulin Delivery Devices Market Outlook, By Reusable (2023-2034) ($MN)
  • Table 8 Global Insulin Delivery Devices Market Outlook, By Disposable (2023-2034) ($MN)
  • Table 9 Global Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2023-2034) ($MN)
  • Table 10 Global Insulin Delivery Devices Market Outlook, By Safety (2023-2034) ($MN)
  • Table 11 Global Insulin Delivery Devices Market Outlook, By Standard (2023-2034) ($MN)
  • Table 12 Global Insulin Delivery Devices Market Outlook, By Insulin Syringes (2023-2034) ($MN)
  • Table 13 Global Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2023-2034) ($MN)
  • Table 14 Global Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2023-2034) ($MN)
  • Table 15 Global Insulin Delivery Devices Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 16 Global Insulin Delivery Devices Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 17 Global Insulin Delivery Devices Market Outlook, By Online Sales (2023-2034) ($MN)
  • Table 18 Global Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 19 Global Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 20 Global Insulin Delivery Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 21 Global Insulin Delivery Devices Market Outlook, By Homecare (2023-2034) ($MN)
  • Table 22 Global Insulin Delivery Devices Market Outlook, By Clinics (2023-2034) ($MN)
  • Table 23 Global Insulin Delivery Devices Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 24 North America Insulin Delivery Devices Market Outlook, By Country (2023-2034) ($MN)
  • Table 25 North America Insulin Delivery Devices Market Outlook, By Product (2023-2034) ($MN)
  • Table 26 North America Insulin Delivery Devices Market Outlook, By Insulin Pumps (2023-2034) ($MN)
  • Table 27 North America Insulin Delivery Devices Market Outlook, By Tubeless (2023-2034) ($MN)
  • Table 28 North America Insulin Delivery Devices Market Outlook, By Tethered (2023-2034) ($MN)
  • Table 29 North America Insulin Delivery Devices Market Outlook, By Insulin Pens (2023-2034) ($MN)
  • Table 30 North America Insulin Delivery Devices Market Outlook, By Reusable (2023-2034) ($MN)
  • Table 31 North America Insulin Delivery Devices Market Outlook, By Disposable (2023-2034) ($MN)
  • Table 32 North America Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2023-2034) ($MN)
  • Table 33 North America Insulin Delivery Devices Market Outlook, By Safety (2023-2034) ($MN)
  • Table 34 North America Insulin Delivery Devices Market Outlook, By Standard (2023-2034) ($MN)
  • Table 35 North America Insulin Delivery Devices Market Outlook, By Insulin Syringes (2023-2034) ($MN)
  • Table 36 North America Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2023-2034) ($MN)
  • Table 37 North America Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2023-2034) ($MN)
  • Table 38 North America Insulin Delivery Devices Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 39 North America Insulin Delivery Devices Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 40 North America Insulin Delivery Devices Market Outlook, By Online Sales (2023-2034) ($MN)
  • Table 41 North America Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 42 North America Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 43 North America Insulin Delivery Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 44 North America Insulin Delivery Devices Market Outlook, By Homecare (2023-2034) ($MN)
  • Table 45 North America Insulin Delivery Devices Market Outlook, By Clinics (2023-2034) ($MN)
  • Table 46 North America Insulin Delivery Devices Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 47 Europe Insulin Delivery Devices Market Outlook, By Country (2023-2034) ($MN)
  • Table 48 Europe Insulin Delivery Devices Market Outlook, By Product (2023-2034) ($MN)
  • Table 49 Europe Insulin Delivery Devices Market Outlook, By Insulin Pumps (2023-2034) ($MN)
  • Table 50 Europe Insulin Delivery Devices Market Outlook, By Tubeless (2023-2034) ($MN)
  • Table 51 Europe Insulin Delivery Devices Market Outlook, By Tethered (2023-2034) ($MN)
  • Table 52 Europe Insulin Delivery Devices Market Outlook, By Insulin Pens (2023-2034) ($MN)
  • Table 53 Europe Insulin Delivery Devices Market Outlook, By Reusable (2023-2034) ($MN)
  • Table 54 Europe Insulin Delivery Devices Market Outlook, By Disposable (2023-2034) ($MN)
  • Table 55 Europe Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2023-2034) ($MN)
  • Table 56 Europe Insulin Delivery Devices Market Outlook, By Safety (2023-2034) ($MN)
  • Table 57 Europe Insulin Delivery Devices Market Outlook, By Standard (2023-2034) ($MN)
  • Table 58 Europe Insulin Delivery Devices Market Outlook, By Insulin Syringes (2023-2034) ($MN)
  • Table 59 Europe Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2023-2034) ($MN)
  • Table 60 Europe Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2023-2034) ($MN)
  • Table 61 Europe Insulin Delivery Devices Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 62 Europe Insulin Delivery Devices Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 63 Europe Insulin Delivery Devices Market Outlook, By Online Sales (2023-2034) ($MN)
  • Table 64 Europe Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 65 Europe Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 66 Europe Insulin Delivery Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 67 Europe Insulin Delivery Devices Market Outlook, By Homecare (2023-2034) ($MN)
  • Table 68 Europe Insulin Delivery Devices Market Outlook, By Clinics (2023-2034) ($MN)
  • Table 69 Europe Insulin Delivery Devices Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 70 Asia Pacific Insulin Delivery Devices Market Outlook, By Country (2023-2034) ($MN)
  • Table 71 Asia Pacific Insulin Delivery Devices Market Outlook, By Product (2023-2034) ($MN)
  • Table 72 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Pumps (2023-2034) ($MN)
  • Table 73 Asia Pacific Insulin Delivery Devices Market Outlook, By Tubeless (2023-2034) ($MN)
  • Table 74 Asia Pacific Insulin Delivery Devices Market Outlook, By Tethered (2023-2034) ($MN)
  • Table 75 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Pens (2023-2034) ($MN)
  • Table 76 Asia Pacific Insulin Delivery Devices Market Outlook, By Reusable (2023-2034) ($MN)
  • Table 77 Asia Pacific Insulin Delivery Devices Market Outlook, By Disposable (2023-2034) ($MN)
  • Table 78 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2023-2034) ($MN)
  • Table 79 Asia Pacific Insulin Delivery Devices Market Outlook, By Safety (2023-2034) ($MN)
  • Table 80 Asia Pacific Insulin Delivery Devices Market Outlook, By Standard (2023-2034) ($MN)
  • Table 81 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Syringes (2023-2034) ($MN)
  • Table 82 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2023-2034) ($MN)
  • Table 83 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2023-2034) ($MN)
  • Table 84 Asia Pacific Insulin Delivery Devices Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 85 Asia Pacific Insulin Delivery Devices Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 86 Asia Pacific Insulin Delivery Devices Market Outlook, By Online Sales (2023-2034) ($MN)
  • Table 87 Asia Pacific Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 88 Asia Pacific Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 89 Asia Pacific Insulin Delivery Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 90 Asia Pacific Insulin Delivery Devices Market Outlook, By Homecare (2023-2034) ($MN)
  • Table 91 Asia Pacific Insulin Delivery Devices Market Outlook, By Clinics (2023-2034) ($MN)
  • Table 92 Asia Pacific Insulin Delivery Devices Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 93 South America Insulin Delivery Devices Market Outlook, By Country (2023-2034) ($MN)
  • Table 94 South America Insulin Delivery Devices Market Outlook, By Product (2023-2034) ($MN)
  • Table 95 South America Insulin Delivery Devices Market Outlook, By Insulin Pumps (2023-2034) ($MN)
  • Table 96 South America Insulin Delivery Devices Market Outlook, By Tubeless (2023-2034) ($MN)
  • Table 97 South America Insulin Delivery Devices Market Outlook, By Tethered (2023-2034) ($MN)
  • Table 98 South America Insulin Delivery Devices Market Outlook, By Insulin Pens (2023-2034) ($MN)
  • Table 99 South America Insulin Delivery Devices Market Outlook, By Reusable (2023-2034) ($MN)
  • Table 100 South America Insulin Delivery Devices Market Outlook, By Disposable (2023-2034) ($MN)
  • Table 101 South America Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2023-2034) ($MN)
  • Table 102 South America Insulin Delivery Devices Market Outlook, By Safety (2023-2034) ($MN)
  • Table 103 South America Insulin Delivery Devices Market Outlook, By Standard (2023-2034) ($MN)
  • Table 104 South America Insulin Delivery Devices Market Outlook, By Insulin Syringes (2023-2034) ($MN)
  • Table 105 South America Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2023-2034) ($MN)
  • Table 106 South America Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2023-2034) ($MN)
  • Table 107 South America Insulin Delivery Devices Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 108 South America Insulin Delivery Devices Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 109 South America Insulin Delivery Devices Market Outlook, By Online Sales (2023-2034) ($MN)
  • Table 110 South America Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 111 South America Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 112 South America Insulin Delivery Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 113 South America Insulin Delivery Devices Market Outlook, By Homecare (2023-2034) ($MN)
  • Table 114 South America Insulin Delivery Devices Market Outlook, By Clinics (2023-2034) ($MN)
  • Table 115 South America Insulin Delivery Devices Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 116 Middle East & Africa Insulin Delivery Devices Market Outlook, By Country (2023-2034) ($MN)
  • Table 117 Middle East & Africa Insulin Delivery Devices Market Outlook, By Product (2023-2034) ($MN)
  • Table 118 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Pumps (2023-2034) ($MN)
  • Table 119 Middle East & Africa Insulin Delivery Devices Market Outlook, By Tubeless (2023-2034) ($MN)
  • Table 120 Middle East & Africa Insulin Delivery Devices Market Outlook, By Tethered (2023-2034) ($MN)
  • Table 121 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Pens (2023-2034) ($MN)
  • Table 122 Middle East & Africa Insulin Delivery Devices Market Outlook, By Reusable (2023-2034) ($MN)
  • Table 123 Middle East & Africa Insulin Delivery Devices Market Outlook, By Disposable (2023-2034) ($MN)
  • Table 124 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2023-2034) ($MN)
  • Table 125 Middle East & Africa Insulin Delivery Devices Market Outlook, By Safety (2023-2034) ($MN)
  • Table 126 Middle East & Africa Insulin Delivery Devices Market Outlook, By Standard (2023-2034) ($MN)
  • Table 127 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Syringes (2023-2034) ($MN)
  • Table 128 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2023-2034) ($MN)
  • Table 129 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2023-2034) ($MN)
  • Table 130 Middle East & Africa Insulin Delivery Devices Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 131 Middle East & Africa Insulin Delivery Devices Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 132 Middle East & Africa Insulin Delivery Devices Market Outlook, By Online Sales (2023-2034) ($MN)
  • Table 133 Middle East & Africa Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 134 Middle East & Africa Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 135 Middle East & Africa Insulin Delivery Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 136 Middle East & Africa Insulin Delivery Devices Market Outlook, By Homecare (2023-2034) ($MN)
  • Table 137 Middle East & Africa Insulin Delivery Devices Market Outlook, By Clinics (2023-2034) ($MN)
  • Table 138 Middle East & Africa Insulin Delivery Devices Market Outlook, By Other End Users (2023-2034) ($MN)